32 results on '"Toivanen R."'
Search Results
2. 946 Identification of castrate-resistant cancer repopulating cells in localised prostate tumours
- Author
-
Murphy, D.G., Toivanen, R., Frydenberg, M., Pedersen, J., Ryan, A., Pook, D., Berman, M., Taylor, R.A., and Risbridger, G.P.
- Published
- 2013
- Full Text
- View/download PDF
3. Breaking through a roadblock in prostate cancer research: An update on human model systems
- Author
-
Toivanen, R., Taylor, R.A., Pook, D.W., Ellem, S.J., and Risbridger, G.P.
- Subjects
- *
PROSTATE cancer prevention , *CANCER research , *HUMAN experimentation , *MOLECULAR genetics , *CELL lines , *XENOGRAFTS - Abstract
Abstract: Prostate cancer is a prevalent disease that affects the aging male population. Whilst there have been significant advances of our biological understanding of the disease, clinical translation of promising agents continues to lag behind. In part, this is due to a paucity of relevant experimental and pre-clinical models required to further develop effective prevention and therapeutic strategies. Genetically modified cell lines fail to entirely represent the genetic and molecular diversity of primary human specimens, particularly from localised disease. Furthermore, primary prostate cancer tissues are extremely difficult to grow in the laboratory and virtually all human models, whether they grow as xenografts in immune-deficient animals or as cell cultures, are genetically modified by the investigator or derived from patients with advanced metastatic disease. In this review, we discuss the latest advances and improvements to current methods of xenografting human primary prostate cancer, and their potential application to translational research. This article is part of a Special Issue entitled ‘Steroids and cancer’. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
4. Structure and superconducting property characterisation of MF Cu/Nb - 46.5 w% Ti superconductors.
- Author
-
Somerkoski, J., Hampshire, D., Jones, H., Toivanen, R., and Lindroos, V.
- Published
- 1987
- Full Text
- View/download PDF
5. High critical current densities of multifilamentary Nb- 46.5w%Ti superconductors.
- Author
-
Somerkoski, J., Laakso, L., Vanhatalo, V., Toivanen, R., and Lindroos, V.
- Published
- 1985
- Full Text
- View/download PDF
6. Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysis.
- Author
-
Kannan A, Clouston D, Frydenberg M, Ilic D, Karim MN, Evans SM, Toivanen R, Risbridger GP, and Taylor RA
- Subjects
- Biomarkers, Tumor analysis, Chromogranin A, Humans, Male, Phosphopyruvate Hydratase, Synaptophysin, Adenocarcinoma pathology, Neuroendocrine Cells chemistry, Neuroendocrine Cells pathology, Prostatic Neoplasms pathology
- Abstract
Objectives: To perform a systematic review and meta-analysis of the literature to understand the variation in the reporting of neuroendocrine staining and determine the influence of reporting neuroendocrine staining at diagnosis on patient outcomes., Methods: Medical databases were searched to identify studies in which adenocarcinoma specimens were stained with any of the following four neuroendocrine markers: chromogranin A (CgA), neuron-specific enolase (NSE), synaptophysin and CD56. The prevalence of neuroendocrine staining and correlation of the prevalence of neuroendocrine staining to patient outcomes were analysed using a random-effects model. All statistical tests were two-sided., Results: Sixty-two studies spanning 7616 patients were analysed. The pooled prevalence for the most common marker, CgA (41%), was similar to that of NSE (39%) and higher than that of synaptophysin (31%). The prevalence of CgA staining was significantly influenced by reporting criteria, where objective thresholds reduced the variation in prevalence to 26%. No correlation was found between CgA prevalence and tumour grade. Patients positive for CgA staining using objective criteria had more rapid biochemical progression (hazard ratio [HR] 1.98, 95% confidence interval [CI] 1.49 to 2.65) and poorer prostate cancer-specific survival (HR 7.03, 95% CI 2.55 to 19.39) compared to negative patients, even among those with low-risk cancers., Conclusion: Discrepancies in the reported prevalence of neuroendocrine cells in adenocarcinoma are driven by the inconsistent scoring criteria. This study unequivocally demonstrates that when neuroendocrine cell staining is assessed with objective criteria it identifies patients with poor clinical outcomes. Future studies are needed to determine the exact quantifiable thresholds for use in reporting neuroendocrine cell staining to identify patients at higher risk of progression., (© 2021 The Authors BJU International © 2021 BJU International.)
- Published
- 2022
- Full Text
- View/download PDF
7. Hidden clues in prostate cancer - Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification.
- Author
-
Toivanen R, Porter LH, Li Z, Clouston D, Risbridger GP, and Taylor RA
- Subjects
- Clinical Decision-Making, Humans, Male, Prognosis, Prostate pathology, Prostatic Neoplasms blood, Prostatic Neoplasms genetics, Prostatic Neoplasms pathology, Risk Assessment, Biomarkers, Tumor blood, Prostate metabolism, Prostate-Specific Antigen blood, Prostatic Neoplasms diagnosis
- Abstract
The heterogeneity of prostate cancer is evident at clinical, morphological and molecular levels. To aid clinical decision making, a three-tiered system for risk stratification is used to designate low-, intermediate-, and high-risk of disease progression. Intermediate-risk prostate cancers are the most frequently diagnosed, and even with common diagnostic features, can exhibit vastly different clinical progression. Thus, improved risk stratification methods are needed to better predict patient outcomes. Here, we provide an overview of the improvements in diagnosis/prognosis arising from advances in pathology reporting of prostate cancer, which can improve risk stratification, especially for patients with intermediate-risk disease. This review discusses updates to pathology reporting of morphological growth patterns, and proposes the utility of integrating prognostic biomarkers or innovative imaging techniques to enhance clinical decision-making. To complement clinical studies, experimental approaches using patient-derived tumors have highlighted important cellular and morphological features associated with aggressive disease that may impact treatment response. The intersection of urology, pathology and scientific disciplines is required to work towards a common goal of understanding disease pathogenesis, improving the stratification of patients with intermediate-risk disease and subsequently defining optimal treatment strategies using precision-based approaches., (Copyright © 2021. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
8. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.
- Author
-
Risbridger GP, Clark AK, Porter LH, Toivanen R, Bakshi A, Lister NL, Pook D, Pezaro CJ, Sandhu S, Keerthikumar S, Quezada Urban R, Papargiris M, Kraska J, Madsen HB, Wang H, Richards MG, Niranjan B, O'Dea S, Teng L, Wheelahan W, Li Z, Choo N, Ouyang JF, Thorne H, Devereux L, Hicks RJ, Sengupta S, Harewood L, Iddawala M, Azad AA, Goad J, Grummet J, Kourambas J, Kwan EM, Moon D, Murphy DG, Pedersen J, Clouston D, Norden S, Ryan A, Furic L, Goode DL, Frydenberg M, Lawrence MG, and Taylor RA
- Subjects
- Animals, Disease Models, Animal, Genome, Humans, Male, Mice, Mice, Inbred NOD, Mice, SCID, Mutation, Neoplasm Metastasis, Organoids metabolism, Prospective Studies, Prostatic Neoplasms drug therapy, Prostatic Neoplasms genetics, Prostatic Neoplasms metabolism, Tissue Banks, Transcriptome, Xenograft Model Antitumor Assays, Drug Evaluation, Preclinical methods, Organoids pathology, Prostatic Neoplasms pathology
- Abstract
Preclinical testing is a crucial step in evaluating cancer therapeutics. We aimed to establish a significant resource of patient-derived xenografts (PDXs) of prostate cancer for rapid and systematic evaluation of candidate therapies. The PDX collection comprises 59 tumors collected from 30 patients between 2012-2020, coinciding with availability of abiraterone and enzalutamide. The PDXs represent the clinico-pathological and genomic spectrum of prostate cancer, from treatment-naïve primary tumors to castration-resistant metastases. Inter- and intra-tumor heterogeneity in adenocarcinoma and neuroendocrine phenotypes is evident from bulk and single-cell RNA sequencing data. Organoids can be cultured from PDXs, providing further capabilities for preclinical studies. Using a 1 x 1 x 1 design, we rapidly identify tumors with exceptional responses to combination treatments. To govern the distribution of PDXs, we formed the Melbourne Urological Research Alliance (MURAL). This PDX collection is a substantial resource, expanding the capacity to test and prioritize effective treatments for prospective clinical trials in prostate cancer., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
9. A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer.
- Author
-
Toivanen R and Furic L
- Subjects
- Disease Progression, Humans, Male, PTEN Phosphohydrolase, Phosphoprotein Phosphatases, Signal Transduction, Prostatic Neoplasms, Proto-Oncogene Proteins c-akt
- Abstract
PTEN loss stimulates prostate tumor progression by sustaining AKT activation. Nowak et al. (2019. J. Cell Biol https://doi.org/10.1083/jcb.201902048) surprisingly show that the AKT-suppressing phosphatase PHLPP2 promotes disease progression in the context of dual PTEN and p53 loss by increasing MYC stability., (© 2019 Toivanen and Furic.)
- Published
- 2019
- Full Text
- View/download PDF
10. Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.
- Author
-
Lawrence MG, Obinata D, Sandhu S, Selth LA, Wong SQ, Porter LH, Lister N, Pook D, Pezaro CJ, Goode DL, Rebello RJ, Clark AK, Papargiris M, Van Gramberg J, Hanson AR, Banks P, Wang H, Niranjan B, Keerthikumar S, Hedwards S, Huglo A, Yang R, Henzler C, Li Y, Lopez-Campos F, Castro E, Toivanen R, Azad A, Bolton D, Goad J, Grummet J, Harewood L, Kourambas J, Lawrentschuk N, Moon D, Murphy DG, Sengupta S, Snow R, Thorne H, Mitchell C, Pedersen J, Clouston D, Norden S, Ryan A, Dehm SM, Tilley WD, Pearson RB, Hannan RD, Frydenberg M, Furic L, Taylor RA, and Risbridger GP
- Subjects
- Animals, Benzamides, Humans, Male, Mice, Inbred NOD, Mice, SCID, Molecular Targeted Therapy, Nitriles, Phenylthiohydantoin pharmacology, Prostatic Neoplasms, Castration-Resistant enzymology, Prostatic Neoplasms, Castration-Resistant genetics, Prostatic Neoplasms, Castration-Resistant pathology, Proto-Oncogene Proteins c-pim-1 antagonists & inhibitors, Proto-Oncogene Proteins c-pim-1 metabolism, RNA Polymerase I antagonists & inhibitors, RNA Polymerase I genetics, RNA Polymerase I metabolism, Ribosomes enzymology, Ribosomes genetics, Time Factors, Tumor Burden drug effects, Xenograft Model Antitumor Assays, Androstenes pharmacology, Antineoplastic Agents pharmacology, Antineoplastic Combined Chemotherapy Protocols pharmacology, Azepines pharmacology, Benzothiazoles pharmacology, Drug Resistance, Neoplasm, Indoles pharmacology, Naphthyridines pharmacology, Phenylthiohydantoin analogs & derivatives, Prostatic Neoplasms, Castration-Resistant drug therapy, Ribosomes drug effects
- Abstract
Background: The intractability of castration-resistant prostate cancer (CRPC) is exacerbated by tumour heterogeneity, including diverse alterations to the androgen receptor (AR) axis and AR-independent phenotypes. The availability of additional models encompassing this heterogeneity would facilitate the identification of more effective therapies for CRPC., Objective: To discover therapeutic strategies by exploiting patient-derived models that exemplify the heterogeneity of CRPC., Design, Setting, and Participants: Four new patient-derived xenografts (PDXs) were established from independent metastases of two patients and characterised using integrative genomics. A panel of rationally selected drugs was tested using an innovative ex vivo PDX culture system., Intervention: The following drugs were evaluated: AR signalling inhibitors (enzalutamide and galeterone), a PARP inhibitor (talazoparib), a chemotherapeutic (cisplatin), a CDK4/6 inhibitor (ribociclib), bromodomain and extraterminal (BET) protein inhibitors (iBET151 and JQ1), and inhibitors of ribosome biogenesis/function (RNA polymerase I inhibitor CX-5461 and pan-PIM kinase inhibitor CX-6258)., Outcome Measurements and Statistical Analysis: Drug efficacy in ex vivo cultures of PDX tissues was evaluated using immunohistochemistry for Ki67 and cleaved caspase-3 levels. Candidate drugs were also tested for antitumour efficacy in vivo, with tumour volume being the primary endpoint. Two-tailed t tests were used to compare drug and control treatments., Results and Limitations: Integrative genomics revealed that the new PDXs exhibited heterogeneous mechanisms of resistance, including known and novel AR mutations, genomic structural rearrangements of the AR gene, and a neuroendocrine-like AR-null phenotype. Despite their heterogeneity, all models were sensitive to the combination of ribosome-targeting agents CX-5461 and CX-6258., Conclusions: This study demonstrates that ribosome-targeting drugs may be effective against diverse CRPC subtypes including AR-null disease, and highlights the potential of contemporary patient-derived models to prioritise treatment strategies for clinical translation., Patient Summary: Diverse types of therapy-resistant prostate cancers are sensitive to a new combination of drugs that inhibit protein synthesis pathways in cancer cells., (Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
11. Changes in emotions and personal goals in primiparous pregnant women during group intervention for fear of childbirth.
- Author
-
Airo Toivanen R, Korja R, Saisto T, Rouhe H, Muotka J, and Salmela-Aro K
- Subjects
- Adult, Delivery, Obstetric psychology, Female, Humans, Infant, Newborn, Parenting psychology, Pregnancy, Randomized Controlled Trials as Topic, Surveys and Questionnaires, Adaptation, Psychological, Fear psychology, Goals, Parturition psychology, Pregnant Women psychology
- Abstract
The changes in emotions, subjective fear of childbirth, and personal goals were examined during a group intervention to treat fear of childbirth (FOC). The objective was to gain a more detailed understanding of the changes occurring during the group intervention of FOC. The changes in emotions, subjective FOC, and personal goals were studied in primiparous pregnant women with severe FOC participating in a group intervention (n = 105). The group intervention contained six sessions during pregnancy and one after childbirth. At every session, the participants filled in a questionnaire regarding their experiences of current positive and negative emotions and the subjective FOC. The participants also set and reported their personal goals in their preparation for childbirth and parenthood. The negative emotions decreased from the beginning of the intervention. The change became significant after the fourth session. The amount of positive emotions increased but became statistically significant only after the delivery. The subjective FOC decreased significantly from the beginning of the intervention. Personal goals shifted from being mainly self-related to being mostly related to parenthood. The group intervention decreased FOC and promoted changes in emotions and personal goals that foster emotional preparedness for childbirth. It seems that the decrease in FOC was made possible through gaining a better capacity to regulate emotions, especially negative emotions. As negative emotions and fear decreased, personal goals simultaneously changed in the direction known to be adaptive for the new life situation as a parent of a newborn.
- Published
- 2018
- Full Text
- View/download PDF
12. Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models.
- Author
-
Risbridger GP, Toivanen R, and Taylor RA
- Subjects
- Animals, Disease Models, Animal, Heterografts, Humans, Male, Mice, Tumor Microenvironment physiology, Cell Line, Tumor, Prostatic Neoplasms pathology
- Abstract
Prostate cancer remains a lethal disease. Preclinical cancer models that accurately represent the tumors of the patients they are intended to help are necessary to test potential therapeutic approaches and to better translate research discoveries. However, research in the prostate cancer field is hampered by the limited number of human cell lines and xenograft models, most of which do not recapitulate the human disease seen in the clinic today. This work reviews the recent advances in human patient-derived xenograft, organoid, and other explant models to address this need. In contrast to other tumor streams, the prostate cancer field is challenged by this approach, yet despite the limitations, patient-derived models remain an integral component of the preclinical testing pathway leading to better treatments for men with prostate cancer., (Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
13. Partners of nulliparous women with severe fear of childbirth: A longitudinal study of psychological well-being.
- Author
-
Ryding EL, Read S, Rouhe H, Halmesmäki E, Salmela-Aro K, Toivanen R, Tokola M, and Saisto T
- Subjects
- Adult, Cesarean Section psychology, Depression psychology, Female, Finland, Humans, Logistic Models, Longitudinal Studies, Male, Parity, Postpartum Period psychology, Pregnancy, Psychiatric Status Rating Scales, Stress Disorders, Post-Traumatic etiology, Surveys and Questionnaires, Depression therapy, Fear psychology, Parturition psychology, Patient Education as Topic methods, Spouses psychology
- Abstract
Background: Little is known about the psychological status of partners of women with severe fear of childbirth (FOC). In this longitudinal study from Helsinki University Central Hospital, we investigated FOC, depression, and posttraumatic stress in the partners of women with severe FOC, and possible effects of group psychoeducation and mode of birth., Methods: During pregnancy, 250 partners of nulliparous women with severe FOC participated, 93 in the intervention group and 157 in the control group. At 3 months postpartum, 52 partners in the intervention group and 93 in the control group participated. Both the partners and the childbearing women filled in the Wijma Delivery Expectancy/Experience Questionnaire and the Edinburgh Postnatal Depression Scale mid-pregnancy as well as 3 months postpartum, when they also filled in the Traumatic Event Scale., Results: Partners of women with severe FOC reported less antenatal and postnatal FOC and fewer depressive symptoms than the childbearing women. No partner reached the threshold of severe FOC. No partner reported a possible posttraumatic stress disorder. Group psychoeducation with relaxation was not associated with better or worse psychological well-being of the partners. An emergency cesarean delivery was associated with a more fearful delivery experience in the partners., Conclusion: Partners of nulliparous women with severe FOC neither seem to suffer from severe FOC nor reported posttraumatic stress symptoms after childbirth. They reported better psychological well-being than the mothers both during pregnancy and after delivery. An unexpected cesarean may be a negative experience even for partners of childbearing women., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
14. Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.
- Author
-
Zou M, Toivanen R, Mitrofanova A, Floch N, Hayati S, Sun Y, Le Magnen C, Chester D, Mostaghel EA, Califano A, Rubin MA, Shen MM, and Abate-Shen C
- Subjects
- Androstenes adverse effects, Animals, Cell Line, Tumor, Cell Transdifferentiation drug effects, Cell Transdifferentiation genetics, Disease Models, Animal, Drug Resistance, Neoplasm genetics, Gene Expression Regulation, Neoplastic drug effects, Humans, Male, Mice, Neuroendocrine Tumors genetics, Neuroendocrine Tumors pathology, Neurons drug effects, Neurons pathology, Prostatic Neoplasms, Castration-Resistant genetics, Prostatic Neoplasms, Castration-Resistant pathology, Receptors, Androgen drug effects, SOXC Transcription Factors genetics, Signal Transduction drug effects, Treatment Outcome, Androstenes administration & dosage, Neuroendocrine Tumors drug therapy, PTEN Phosphohydrolase genetics, Prostatic Neoplasms, Castration-Resistant drug therapy, Receptors, Androgen genetics, Tumor Suppressor Protein p53 genetics
- Abstract
Current treatments for castration-resistant prostate cancer (CRPC) that target androgen receptor (AR) signaling improve patient survival, yet ultimately fail. Here, we provide novel insights into treatment response for the antiandrogen abiraterone by analyses of a genetically engineered mouse (GEM) model with combined inactivation of Trp53 and Pten , which are frequently comutated in human CRPC. These NPp53 mice fail to respond to abiraterone and display accelerated progression to tumors resembling treatment-related CRPC with neuroendocrine differentiation (CRPC-NE) in humans. Cross-species computational analyses identify master regulators of adverse response that are conserved with human CRPC-NE, including the neural differentiation factor SOX11 , which promotes neuroendocrine differentiation in cells derived from NPp53 tumors. Furthermore, abiraterone-treated NPp53 prostate tumors contain regions of focal and/or overt neuroendocrine differentiation, distinguished by their proliferative potential. Notably, lineage tracing in vivo provides definitive and quantitative evidence that focal and overt neuroendocrine regions arise by transdifferentiation of luminal adenocarcinoma cells. These findings underscore principal roles for TP53 and PTEN inactivation in abiraterone resistance and progression from adenocarcinoma to CRPC-NE by transdifferentiation. Significance: Understanding adverse treatment response and identifying patients likely to fail treatment represent fundamental clinical challenges. By integrating analyses of GEM models and human clinical data, we provide direct genetic evidence for transdifferentiation as a mechanism of drug resistance as well as for stratifying patients for treatment with antiandrogens. Cancer Discov; 7(7); 736-49. ©2017 AACR. See related commentary by Sinha and Nelson, p. 673 This article is highlighted in the In This Issue feature, p. 653 ., (©2017 American Association for Cancer Research.)
- Published
- 2017
- Full Text
- View/download PDF
15. Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.
- Author
-
Toivanen R and Shen MM
- Subjects
- Animals, Cell Differentiation, Epithelium embryology, Humans, Male, Prostate anatomy & histology, Sex Characteristics, Hormones metabolism, Organogenesis, Prostate cytology, Prostate embryology
- Abstract
Prostate organogenesis is a complex process that is primarily mediated by the presence of androgens and subsequent mesenchyme-epithelial interactions. The investigation of prostate development is partly driven by its potential relevance to prostate cancer, in particular the apparent re-awakening of key developmental programs that occur during tumorigenesis. However, our current knowledge of the mechanisms that drive prostate organogenesis is far from complete. Here, we provide a comprehensive overview of prostate development, focusing on recent findings regarding sexual dimorphism, bud induction, branching morphogenesis and cellular differentiation., (© 2017. Published by The Company of Biologists Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
16. Basal Progenitors Contribute to Repair of the Prostate Epithelium Following Induced Luminal Anoikis.
- Author
-
Toivanen R, Mohan A, and Shen MM
- Subjects
- Animals, Cell Death genetics, Cell Differentiation genetics, Cell Proliferation genetics, Epithelial Cells metabolism, Humans, Male, Mice, Prostate growth & development, Prostate metabolism, Stem Cells metabolism, Anoikis genetics, Cadherins genetics
- Abstract
Contact with the extracellular matrix is essential for maintenance of epithelial cells in many tissues, while in its absence epithelial cells can detach and undergo anoikis. Here, we show that anoikis of luminal cells in the prostate epithelium is followed by a program of tissue repair that is mediated in part by differentiation of basal epithelial cells to luminal cells. We describe a mouse model in which inducible deletion of E-cadherin in prostate luminal cells results in their apoptotic cell death by anoikis, in the absence of phenotypic effects in the surrounding stroma. Quantitative assessments of proliferation and cell death in the luminal and basal compartments indicate that basal cells can rapidly generate luminal cells. Thus, our findings identify a role for basal-to-luminal differentiation in prostate epithelial repair, and provide a normal context to analogous processes that may occur during prostate cancer initiation., (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
17. Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
- Author
-
Leach DA, Need EF, Toivanen R, Trotta AP, Palethorpe HM, Tamblyn DJ, Kopsaftis T, England GM, Smith E, Drew PA, Pinnock CB, Lee P, Holst J, Risbridger GP, Chopra S, DeFranco DB, Taylor RA, and Buchanan G
- Published
- 2015
- Full Text
- View/download PDF
18. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
- Author
-
Leach DA, Need EF, Toivanen R, Trotta AP, Palethorpe HM, Tamblyn DJ, Kopsaftis T, England GM, Smith E, Drew PA, Pinnock CB, Lee P, Holst J, Risbridger GP, Chopra S, DeFranco DB, Taylor RA, and Buchanan G
- Subjects
- Aged, Aged, 80 and over, Androgens pharmacology, Animals, Apoptosis drug effects, Blotting, Western, Case-Control Studies, Cell Adhesion drug effects, Cell Movement drug effects, Cell Proliferation drug effects, Chromatin Immunoprecipitation, Follow-Up Studies, Humans, Immunoenzyme Techniques, Male, Middle Aged, Myofibroblasts drug effects, Myofibroblasts metabolism, Neoplasm Grading, Neoplasm Invasiveness, Orchiectomy, Prognosis, Prostatic Hyperplasia drug therapy, Prostatic Hyperplasia metabolism, Prostatic Neoplasms drug therapy, Prostatic Neoplasms metabolism, RNA, Messenger genetics, Real-Time Polymerase Chain Reaction, Receptors, Androgen genetics, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Stromal Cells drug effects, Stromal Cells metabolism, Tissue Array Analysis, Tumor Cells, Cultured, Myofibroblasts pathology, Prostatic Hyperplasia pathology, Prostatic Neoplasms pathology, Receptors, Androgen metabolism, Stromal Cells pathology, Tumor Microenvironment
- Abstract
Androgen receptor (AR) signaling in stromal cells is important in prostate cancer, yet the mechanisms underpinning stromal AR contribution to disease development and progression remain unclear. Using patient-matched benign and malignant prostate samples, we show a significant association between low AR levels in cancer associated stroma and increased prostate cancer-related death at one, three and five years post-diganosis, and in tissue recombination models with primary prostate cancer cells that low stromal AR decreases castration-induced apoptosis. AR-regulation was found to be different in primary human fibroblasts isolated from adjacent to cancerous and non-cancerous prostate epithelia, and to represent altered activation of myofibroblast pathways involved in cell cycle, adhesion, migration, and the extracellular matrix (ECM). Without AR signaling, the fibroblast-derived ECM loses the capacity to promote attachment of both myofibroblasts and cancer cells, is less able to prevent cell-matrix disruption, and is less likely to impede cancer cell invasion. AR signaling in prostate cancer stroma appears therefore to alter patient outcome by maintaining an ECM microenvironment inhibitory to cancer cell invasion. This paper provides comprehensive insight into AR signaling in the non-epithelial prostate microenvironment, and a resource from which the prognostic and therapeutic implications of stromal AR levels can be further explored.
- Published
- 2015
- Full Text
- View/download PDF
19. Life satisfaction, general well-being and costs of treatment for severe fear of childbirth in nulliparous women by psychoeducative group or conventional care attendance.
- Author
-
Rouhe H, Salmela-Aro K, Toivanen R, Tokola M, Halmesmäki E, and Saisto T
- Subjects
- Adult, Female, Finland, Health Status, Humans, Maternal Health Services economics, Parity, Pregnancy, Prenatal Education economics, Quality of Life, Surveys and Questionnaires, Fear psychology, Health Care Costs, Maternal Welfare, Parturition psychology, Personal Satisfaction, Psychotherapy, Group economics, Relaxation Therapy economics
- Abstract
Objective: Fear of childbirth is a common reason for seeking cesarean section. It is important to consider outcomes and costs associated with alternative treatment and delivery mode. We compared well-being and costs of group psychoeducation and conventional care for fear of childbirth., Design: Randomized controlled trial., Population: A total of 371 nulliparous women scoring over the 95th centile in the Wijma Delivery Expectancy Questionnaire (W-DEQ) during the first trimester., Setting: Finland, data from obstetrical patient records and questionnaires., Methods: Randomization to group psychoeducation with relaxation (six sessions during pregnancy, one after childbirth, n = 131), or surveillance and referral on demand (n = 240)., Main Outcome Measures: All costs in maternity care during pregnancy, delivery and postnatally according to Diagnoses Related Groups. Life satisfaction and general well-being 3 months after childbirth (by a Satisfaction with Life Scale and Well-being Visual Analogue Scale)., Results: The groups did not differ in total direct costs (€3786/woman in psychoeducative group and €3830/woman in control group), nor in life satisfaction or general well-being. Although only 76 (30%) of the women assigned to the surveillance were referred to special maternity care and 36 (15%) attended advanced prenatal classes, costs in the psychoeducation group did not exceed the costs of the controls, mostly because of the greater number of uncomplicated vaginal deliveries (63% vs. 47%, p = 0.005)., Conclusions: Through an association with safer childbirth and equal well-being after delivery, psychoeducative group treatment for nulliparous women with fear of childbirth can be a recommended choice for the same overall costs as conventional treatment., (© 2015 Nordic Federation of Societies of Obstetrics and Gynecology.)
- Published
- 2015
- Full Text
- View/download PDF
20. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
- Author
-
Risbridger GP, Taylor RA, Clouston D, Sliwinski A, Thorne H, Hunter S, Li J, Mitchell G, Murphy D, Frydenberg M, Pook D, Pedersen J, Toivanen R, Wang H, Papargiris M, Lawrence MG, and Bolton DM
- Subjects
- Aged, Animals, Carcinoma, Intraductal, Noninfiltrating mortality, Carcinoma, Intraductal, Noninfiltrating surgery, Genetic Predisposition to Disease, Heredity, Heterografts, Humans, Incidence, Kaplan-Meier Estimate, Male, Mice, Inbred NOD, Mice, SCID, Middle Aged, Neoplasm Transplantation, Pedigree, Phenotype, Proportional Hazards Models, Prostatectomy, Prostatic Neoplasms mortality, Prostatic Neoplasms surgery, Risk Factors, Time Factors, Treatment Outcome, BRCA2 Protein genetics, Carcinoma, Intraductal, Noninfiltrating genetics, Carcinoma, Intraductal, Noninfiltrating pathology, Mutation, Prostatic Neoplasms genetics, Prostatic Neoplasms pathology
- Abstract
Background: Intraductal carcinoma of the prostate (IDC-P) is a distinct clinicopathologic entity associated with aggressive prostate cancer (PCa). PCa patients carrying a breast cancer 2, early onset (BRCA2) germline mutation exhibit highly aggressive tumours with poor prognosis., Objective: To investigate the presence and implications of IDC-P in men with a strong family history of PCa who either carry a BRCA2 pathogenic mutation or do not carry the mutation (BRCAX)., Design, Setting, and Participants: Patient-derived xenografts (PDXs) were generated from three germline BRCA2 mutation carriers and one BRCAX patient. Specimens were examined for histologic evidence of IDC-P. Whole-genome copy number analysis (WG-CNA) was performed on IDC-P from a primary and a matched PDX specimen., Outcome Measurements and Statistical Analysis: The incidence of IDC-P and association with overall survival for BRCA2 and BRCAX patients were determined using Kaplan-Meier analysis., Results and Limitations: PDXs from BRCA2 tumours showed increased incidence of IDC-P compared with sporadic PCa (p=0.015). WG-CNA confirmed that the genetic profile of IDC-P from a matched (primary and PDX) BRCA2 tumour was similar. The incidence of IDC-P was significantly increased in BRCA2 carriers (42%, n=33, p=0.004) but not in BRCAX patients (25.8%, n=62, p=0.102) when both groups were compared with sporadic cases (9%, n=32). BRCA2 carriers and BRCAX patients with IDC-P had significantly worse overall and PCa-specific survival compared with BRCA2 carriers and BRCAX patients without IDC-P (hazard ratio [HR]: 16.9, p=0.0064 and HR: 3.57, p=0.0086, respectively)., Conclusions: PDXs revealed IDC-P in patients with germline BRCA2 mutations or BRCAX classification, identifying aggressive tumours with poor survival even when the stage and grade of cancer at diagnosis were similar. Further studies of the prognostic significance of IDC-P in sporadic PCa are warranted., Patient Summary: Intraductal carcinoma of the prostate is common in patients with familial prostate cancer and is associated with poor outcomes. This finding affects genetic counselling and identifies patients in whom earlier multimodality treatment may be required., (Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
21. Group psychoeducation with relaxation for severe fear of childbirth improves maternal adjustment and childbirth experience--a randomised controlled trial.
- Author
-
Rouhe H, Salmela-Aro K, Toivanen R, Tokola M, Halmesmäki E, Ryding EL, and Saisto T
- Subjects
- Adaptation, Psychological, Delivery, Obstetric psychology, Female, Humans, Postpartum Period psychology, Pregnancy, Pregnancy Complications psychology, Pregnant Women psychology, Social Support, Surveys and Questionnaires, Fear psychology, Mothers psychology, Parturition psychology, Patient Education as Topic methods, Psychotherapy, Group methods, Relaxation Therapy methods
- Abstract
Background: Previous studies on the treatment of women with fear of childbirth have focused on the delivery mode. Women with fear of childbirth often suffer from anxiety and/or depression, and treatment therefore also needs to target postnatal psychological well-being and the early mother-infant relationship., Methods: Three hundred and seventy-one nulliparous women out of 4575 scored ≥100 in prospective screening (Wijma Delivery Expectancy Questionnaire, W-DEQ-A), indicating severe fear of childbirth. These women were randomised to psychoeducative group intervention with relaxation (n = 131; six sessions during pregnancy, one postnatal) or to conventional care (n = 240) by community nurses (referral if necessary). Psycho-emotional and psychosocial evaluations [Edinburgh Postnatal Depression Scale (EPDS), social support, Maternal Adjustment and Attitudes (MAMA), Traumatic Events Scale (TES) and the Wijma Delivery Experience Questionnaire (W-DEQ-B)] were completed twice during pregnancy and/or 3 months postpartum., Results: Postnatal maternal adjustment (MAMA mean score 38.1 ± 4.3 versus 35.7 ± 5.0, p = 0.001) and childbirth experience (mean W-DEQ-B sum score 63.0 ± 29 versus 73.7 ± 32, p = 0.008) were better in the intervention group compared with controls. In hierarchical regression, social support, participating in intervention, and less fearful childbirth experience predicted better maternal adjustment. The level of postnatal depressive symptoms was significantly lower in the intervention group (mean sum score 6.4 ± 5.4 versus 8.0 ± 5.9 p = 0.04). There were no differences in the frequency of post-traumatic stress symptoms between the groups., Conclusions: In nulliparous women with severe fear of childbirth, participation in a targeted psychoeducative group resulted in better maternal adjustment, a less fearful childbirth experience and fewer postnatal depressive symptoms, compared with conventional care.
- Published
- 2015
- Full Text
- View/download PDF
22. Single luminal epithelial progenitors can generate prostate organoids in culture.
- Author
-
Chua CW, Shibata M, Lei M, Toivanen R, Barlow LJ, Bergren SK, Badani KK, McKiernan JM, Benson MC, Hibshoosh H, and Shen MM
- Subjects
- Animals, Cell Culture Techniques, Cell Line, Tumor, Cell Lineage, Cells, Cultured, Epithelial Cells metabolism, Flow Cytometry, Homeodomain Proteins metabolism, Humans, Luminescent Proteins genetics, Luminescent Proteins metabolism, Male, Mice, 129 Strain, Mice, Inbred C57BL, Mice, Transgenic, Microscopy, Fluorescence, Organoids metabolism, Phenotype, Prostate metabolism, Prostatic Neoplasms, Castration-Resistant metabolism, Prostatic Neoplasms, Castration-Resistant pathology, Single-Cell Analysis methods, Stem Cells metabolism, Time Factors, Transcription Factors metabolism, Epithelial Cells cytology, Organoids cytology, Prostate cytology, Stem Cells cytology
- Abstract
The intrinsic ability to exhibit self-organizing morphogenetic properties in ex vivo culture may represent a general property of tissue stem cells. Here we show that single luminal stem/progenitor cells can generate prostate organoids in a three-dimensional culture system in the absence of stroma. Organoids generated from CARNs (castration-resistant Nkx3.1-expressing cells) or normal prostate epithelia exhibit tissue architecture containing luminal and basal cells, undergo long-term expansion in culture and exhibit functional androgen receptor signalling. Lineage-tracing demonstrates that luminal cells are favoured for organoid formation and generate basal cells in culture. Furthermore, tumour organoids can initiate from CARNs after oncogenic transformation and from mouse models of prostate cancer, and can facilitate analyses of drug response. Finally, we provide evidence supporting the feasibility of organoid studies of human prostate tissue. Our studies underscore the progenitor properties of luminal cells, and identify in vitro approaches for studying prostate biology.
- Published
- 2014
- Full Text
- View/download PDF
23. Luminal cells are favored as the cell of origin for prostate cancer.
- Author
-
Wang ZA, Toivanen R, Bergren SK, Chambon P, and Shen MM
- Subjects
- Animals, Cell Lineage, Epithelial Cells metabolism, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Male, Mice, Mice, Inbred C57BL, Neoplastic Stem Cells metabolism, Neoplastic Stem Cells pathology, PTEN Phosphohydrolase genetics, PTEN Phosphohydrolase metabolism, Prostatic Neoplasms metabolism, Proto-Oncogene Proteins c-myc genetics, Proto-Oncogene Proteins c-myc metabolism, Receptors, Tumor Necrosis Factor, Member 25 genetics, Receptors, Tumor Necrosis Factor, Member 25 metabolism, Transcription Factors genetics, Transcription Factors metabolism, Epithelial Cells pathology, Prostatic Neoplasms pathology
- Abstract
The identification of cell types of origin for cancer has important implications for tumor stratification and personalized treatment. For prostate cancer, the cell of origin has been intensively studied, but it has remained unclear whether basal or luminal epithelial cells, or both, represent cells of origin under physiological conditions in vivo. Here, we use a novel lineage-tracing strategy to assess the cell of origin in a diverse range of mouse models, including Nkx3.1(+/-); Pten(+/-), Pten(+/-), Hi-Myc, and TRAMP mice, as well as a hormonal carcinogenesis model. Our results show that luminal cells are consistently the observed cell of origin for each model in situ; however, explanted basal cells from these mice can generate tumors in grafts. Consequently, we propose that luminal cells are favored as cells of origin in many contexts, whereas basal cells only give rise to tumors after differentiation into luminal cells., (Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
24. A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors.
- Author
-
Toivanen R, Frydenberg M, Murphy D, Pedersen J, Ryan A, Pook D, Berman DM, Taylor RA, and Risbridger GP
- Subjects
- Androgen Antagonists therapeutic use, Animals, Apoptosis, Heterografts, Humans, Male, Prostatic Neoplasms drug therapy, Prostatic Neoplasms surgery, Orchiectomy, Prostatic Neoplasms pathology
- Abstract
A lack of clinically relevant experimental models of human prostate cancer hampers evaluation of potential therapeutic agents. Currently, androgen deprivation therapy is the gold standard treatment for advanced prostate cancer, but inevitably, a subpopulation of cancer cells survives and repopulates the tumor. Tumor cells that survive androgen withdrawal are critical therapeutic targets for more effective treatments, but current model systems cannot determine when they arise in disease progression and are unable to recapitulate variable patient response to treatment. A model system was developed in which stromal-supported xenografts from multiple patients with early-stage localized disease can be tested for response to castration. The histopathology of these xenografts mimicked the original tumors, and short-term host castration resulted in reduced proliferation and increased apoptosis in tumor cells. After 4 weeks of castration, residual populations of quiescent, stem-like tumor cells remained. Without subsequent treatment, these residual cells displayed regenerative potential, because testosterone readministration resulted in emergence of rapidly proliferating tumors. Therefore, this model may be useful for revealing potential cellular targets in prostate cancer, which exist before the onset of aggressive incurable disease. Specific eradication of these regenerative tumor cells that survive castration could then confer survival benefits for patients.
- Published
- 2013
- Full Text
- View/download PDF
25. A preclinical xenograft model of prostate cancer using human tumors.
- Author
-
Lawrence MG, Taylor RA, Toivanen R, Pedersen J, Norden S, Pook DW, Frydenberg M, Papargiris MM, Niranjan B, Richards MG, Wang H, Collins AT, Maitland NJ, and Risbridger GP
- Subjects
- Animals, Cell Culture Techniques, Cell Separation methods, Coculture Techniques, Drug Evaluation, Preclinical, Humans, Kidney surgery, Male, Mice, Mice, SCID, Seminal Vesicles pathology, Prostatic Neoplasms pathology, Transplantation, Heterologous methods, Xenograft Model Antitumor Assays
- Abstract
Most cases of prostate cancer are now diagnosed as moderate-grade localized disease. These tumor specimens are important tools in the discovery and translation of prostate cancer research; however, unlike more advanced tumors, they are notoriously difficult to grow in the laboratory. We developed a system for efficiently xenografting localized human prostate cancer tissue, and we adapted this protocol to study the interactions between the specific subsets of epithelial and stromal cells. Fresh prostate tissues or isolated epithelial cells are recombined with mouse seminal vesicle mesenchyme (SVM) and grafted under the renal capsule of immunodeficient mice for optimum growth and survival. Alternatively, mouse mesenchyme can be replaced with human prostate fibroblasts in order to determine their contribution to tumor progression. Grafts can be grown for several months to determine the effectiveness of novel therapeutic compounds when administered to host mice, thereby paving the way for personalizing the treatment of individual prostate cancers.
- Published
- 2013
- Full Text
- View/download PDF
26. Obstetric outcome after intervention for severe fear of childbirth in nulliparous women - randomised trial.
- Author
-
Rouhe H, Salmela-Aro K, Toivanen R, Tokola M, Halmesmäki E, and Saisto T
- Subjects
- Adult, Delivery, Obstetric psychology, Female, Finland, Humans, Parity, Patient Satisfaction, Pregnancy, Fear, Parturition psychology, Patient Education as Topic methods, Pregnancy Outcome psychology, Psychotherapy methods
- Abstract
Objective: To compare the numbers of vaginal deliveries and delivery satisfaction among women with fear of childbirth randomised to either psychoeducation or conventional surveillance during pregnancy., Design: Randomised controlled trial., Setting: Maternity unit of Helsinki University Central Hospital., Population: Fear of childbirth was screened during early pregnancy by the Wijma Delivery Expectancy Questionnaire (W-DEQ-A). Of 4575 screened nulliparous women, 371 (8.1%) scored ≥ 100, showing severe fear of childbirth., Methods: Women with W-DEQ-A ≥ 100 were randomised to intervention (n = 131) (psychoeducative group therapy, six sessions during pregnancy and one after childbirth) or control (n = 240) (care by community nurses and referral if necessary) groups. Obstetric data were collected from patient records and delivery satisfaction was examined by questionnaire., Main Outcome Measures: Delivery mode and satisfaction., Results: Women randomised to the intervention group more often had spontaneous vaginal delivery (SVD) than did controls (63.4% versus 47.5%, P = 0.005) and fewer caesarean sections (CSs) (22.9% versus 32.5%, P = 0.05). SVD was more frequent and CSs were less frequent among those who actually participated in intervention (n = 90) compared with controls who had been referred to consultation (n = 106) (SVD: 65.6% versus 47.2%, P = 0.014; CS: 23.3% versus 38.7%, P = 0.031). Women in intervention more often had a very positive delivery experience (36.1% versus 22.8%, P = 0.04, n = 219)., Conclusions: To decrease the number of CSs, appropriate treatment for fear of childbirth is important. This study shows positive effects of psychoeducative group therapy in nulliparous women with severe fear of childbirth in terms of fewer CSs and more satisfactory delivery experiences relative to control women with a similar severe fear of childbirth., (© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.)
- Published
- 2013
- Full Text
- View/download PDF
27. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.
- Author
-
Taylor RA, Toivanen R, Frydenberg M, Pedersen J, Harewood L, Collins AT, Maitland NJ, and Risbridger GP
- Subjects
- AC133 Antigen, Animals, Cell Differentiation physiology, Epithelial Cells immunology, Epithelial Cells metabolism, Epithelial Cells pathology, Humans, Immunohistochemistry, Male, Mice, Mice, SCID, Prostatic Neoplasms metabolism, Antigens, CD metabolism, Glycoproteins metabolism, Peptides metabolism, Prostatic Neoplasms immunology, Prostatic Neoplasms pathology
- Abstract
Normal prostatic epithelium is composed of basal and luminal cells. Prostate cancer can be initiated in both benign basal and luminal stem cells, but because basal cell markers are not expressed in patient tumors, the former result was unexpected. Since the cells of origin of prostate cancer are important therapeutic targets, we sought to provide further proof that basal stem cells have tumorigenic potential. Prostatic basal cells were enriched based on α2β1integrin(hi) expression and further enriched for stem cells using CD133 in nontumorigenic BPH-1 cells. Human embryonic stem cells (hESCs) were also used as a source of normal stem cells. To test their tumorigenicity, we used two alternate stromal-based approaches; (a) recombination with human cancer-associated fibroblasts (CAFs) or (b) recombination with embryonic stroma (urogenital mesenchyme) and treated host mice with testosterone and 17β-estradiol. Enriched α2β1integrin(hi) basal cells from BPH-1 cells resulted in malignant tumor formation using both assays of tumorigenicity. Surprisingly, the tumorigenic potential did not reside in the CD133(+) stem cells but was consistently observed in the CD133(-) population. CAFs also failed to induce prostatic tumors from hESCs. These data confirmed that benign human basal cells include cells of origin of prostate cancer and reinforced their importance as therapeutic targets. In addition, our data suggested that the more proliferative CD133(-) basal cells are more susceptible to tumorigenesis compared to the CD133(+)-enriched stem cells. These findings challenge the current dogma that normal stem cells and cells of origin of cancer are the same cell type(s)., (Copyright © 2012 AlphaMed Press.)
- Published
- 2012
- Full Text
- View/download PDF
28. Brief report: a bioassay to identify primary human prostate cancer repopulating cells.
- Author
-
Toivanen R, Berman DM, Wang H, Pedersen J, Frydenberg M, Meeker AK, Ellem SJ, Risbridger GP, and Taylor RA
- Subjects
- Aged, Animals, Animals, Newborn, Humans, Integrin alpha2beta1 metabolism, Male, Mesoderm pathology, Mesoderm transplantation, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Middle Aged, Neoplasm Transplantation methods, Phenotype, Prostatic Neoplasms genetics, Prostatic Neoplasms metabolism, Transplantation, Heterologous methods, Biological Assay methods, Neoplastic Stem Cells pathology, Prostatic Neoplasms pathology
- Abstract
Cancer cells are heterogeneous in both their phenotypes and ability to promote tumor growth and spread. Xenografting is used to identify the most highly capable cells of regenerating tumors, referred to as cancer repopulating cells. Because prostate cancers (PCa's) rarely grow as xenografts, indentifying PCa repopulating cells has not been possible. Here, we report improved methods to xenograft localized primary PCa tissues using chimeric grafts with neonatal mouse mesenchyme. Xenograft survival of tumor tissue was significantly increased by neonatal mesenchyme (six of six patients, 66% of grafts, versus four of six patients, 41% of grafts) and doubled the proliferation index of xenografted cancer cells. When applied to isolated PCa cells, neonatal mesenchyme effectively reconstituted PCa's and increased xenograft survival (four of nine patients; 32% of grafts with mesenchyme and 0% without), and supported active cancer cell proliferation. Using this assay, we showed that unfractionated α2β1integrin(hi) and α2β1integrin(lo) cells from primary localized PCa's demonstrated tumor formation at comparable rates, similar to previous reports using metastatic specimens. Thus, this new protocol efficiently established tumors and enabled proliferative expansion of both intact tumor tissue and fractionated cancer cells, providing a bioassay to identify and therapeutically target PCa repopulating cells., (Copyright © 2011 AlphaMed Press.)
- Published
- 2011
- Full Text
- View/download PDF
29. Stem cells in prostate cancer: treating the root of the problem.
- Author
-
Taylor RA, Toivanen R, and Risbridger GP
- Subjects
- Animals, Cell Differentiation physiology, Disease Progression, Humans, Male, Neoplasms, Hormone-Dependent pathology, Neoplastic Stem Cells pathology, Prostatic Neoplasms pathology
- Abstract
Prostate cancer is a hormone-dependent, epithelial-derived tumor, resulting from uncontrolled growth of genetically unstable transformed cells. Stem cells are therapeutic targets for prostate cancer, but as disease progression occurs over decades, the imperative is to identify and target the cancer-repopulating cell (CRC) that maintains malignant clones. In order to achieve this goal, we will review the current knowledge of three specific types of cells, their origins, and their differentiation potential. The first is the normal stem cell, the second is the cancer cell of origin, and the third is the CRC. Specifically, we review three proposed models of stem cell differentiation in normal tissues, including linear, bidirectional, and independent lineages. We consider evidence of the cancer cell of origin arising from both basal and luminal cells. Finally, we discuss the limited data available on the identity and characterization of CRCs in localized and castrate-resistant prostate cancer, which is where we believe the focus of future research efforts should be directed. Ultimately, understanding the intrinsic or extrinsic influences that dictate the behavior of these unique cells will be instrumental in facilitating the development of new therapeutic targets for prostate cancer.
- Published
- 2010
- Full Text
- View/download PDF
30. Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.
- Author
-
McPherson SJ, Hussain S, Balanathan P, Hedwards SL, Niranjan B, Grant M, Chandrasiri UP, Toivanen R, Wang Y, Taylor RA, and Risbridger GP
- Subjects
- Analysis of Variance, Androgens metabolism, Animals, Cell Line, Tumor, Estrogen Receptor beta agonists, Gene Expression Profiling, Humans, Immunohistochemistry, Male, Mice, Mice, Knockout, Prostate metabolism, Tumor Necrosis Factor-alpha genetics, Apoptosis physiology, Estrogen Receptor beta metabolism, Hyperplasia metabolism, Prostate pathology, Prostatic Neoplasms metabolism, Tumor Necrosis Factor-alpha metabolism
- Abstract
Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are androgen-dependent diseases commonly treated by inhibiting androgen action. However, androgen ablation or castration fail to target androgen-independent cells implicated in disease etiology and recurrence. Mechanistically different to castration, this study shows beneficial proapoptotic actions of estrogen receptor-beta (ERbeta) in BPH and PCa. ERbeta agonist induces apoptosis in prostatic stromal, luminal and castrate-resistant basal epithelial cells of estrogen-deficient aromatase knock-out mice. This occurs via extrinsic (caspase-8) pathways, without reducing serum hormones, and perturbs the regenerative capacity of the epithelium. TNFalpha knock-out mice fail to respond to ERbeta agonist, demonstrating the requirement for TNFalpha signaling. In human tissues, ERbeta agonist induces apoptosis in stroma and epithelium of xenografted BPH specimens, including in the CD133(+) enriched putative stem/progenitor cells isolated from BPH-1 cells in vitro. In PCa, ERbeta causes apoptosis in Gleason Grade 7 xenografted tissues and androgen-independent cells lines (PC3 and DU145) via caspase-8. These data provide evidence of the beneficial effects of ERbeta agonist on epithelium and stroma of BPH, as well as androgen-independent tumor cells implicated in recurrent disease. Our data are indicative of the therapeutic potential of ERbeta agonist for treatment of PCa and/or BPH with or without androgen withdrawal.
- Published
- 2010
- Full Text
- View/download PDF
31. Therapeutic group psychoeducation and relaxation in treating fear of childbirth.
- Author
-
Saisto T, Toivanen R, Salmela-Aro K, and Halmesmäki E
- Subjects
- Adult, Cesarean Section statistics & numerical data, Female, Humans, Pregnancy, Fear psychology, Parturition psychology, Psychotherapy, Group, Relaxation Therapy
- Abstract
Background: The increase in the numbers of women fearing childbirth and requesting cesarean sections call for new forms of antenatal treatment., Methods: Finnish nulliparous women experiencing severe fear of childbirth (experimental group, n = 102) attended 5 group sessions with a psychologist, once together with a midwife, during the third trimester. One session was held 3 months after the delivery. Each session consisted of a discussion of fear and feelings towards the impending birth and parenthood in a psychotherapeutic atmosphere and of relaxation exercises focused on an imaginary childbirth. The results were compared with those of 85 women treated for fear of childbirth by 2 appointments with an obstetrician (conventional treatment)., Results: Before the sessions, among the women in the experimental group, scored fear of childbirth, on a scale of one to ten, was 6.9+/-2.0 (SD), which is similar to the score of those receiving conventional treatment (6.0+/-1.6). After the sessions, 84 women in the experimental group (82.4%) and 57 in the conventional treatment group (67.1%) chose to have a vaginal delivery (p = 0.02). The women in the experimental treatment group rated the helpfulness of the sessions 8.5+/-1.6 on a scale where 10 was maximum help and 1 no help at all, and mentioned "sharing their feelings" twice as often as "receiving information" as the most helpful factor in relieving fear., Conclusions: Group psychoeducation and relaxation exercises were well received and rated as very helpful. More cesarean section requests were withdrawn than in the comparison group and in previous studies.
- Published
- 2006
- Full Text
- View/download PDF
32. [Population study of antibodies to some potential pathogens of spondyloarthopathies: the study of the Chukotka population].
- Author
-
Guseva IA, Uksila J, Erdes Sh, Toivanen R, and Benevolenskaia LI
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Bacterial immunology, Catchment Area, Health, Child, Female, Humans, Immunoglobulin A immunology, Immunoglobulin G immunology, Immunoglobulin M immunology, Male, Middle Aged, Population Surveillance, Russia epidemiology, Spondylitis, Ankylosing ethnology, Enterobacteriaceae Infections immunology, HLA Antigens immunology, Spondylitis, Ankylosing immunology
- Abstract
The paper presents the results of the study of specific immune response stimulated by some enterobacteria in populations with high incidence of HLA-B27. A, M and G antibodies to Yersinia, Clebsiella, Salmonella and Campilobacter were studied on 292 plasma samples. The levels of the antibodies varied with anthropological parameters of the examinees (gender, age, nationality). The presence of the gene HLA-B27 in the genotype levels gender dimorphism of the specific humoral immune response. This may be of importance in pathogenesis of spondyloarthropathies which occur more frequently in men.
- Published
- 1999
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.